4D Molecular Therapeutics Inc (NAS:FDMT)
$ 11.85 +0.23 (+1.94%) Market Cap: 619.21 Mil Enterprise Value: 248.85 Mil PE Ratio: 0 PB Ratio: 1.37 GF Score: 55/100

4D Molecular Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2026 / 05:30PM GMT
Release Date Price: $9.42 (+8.65%)
Operator

Welcome to the Annual Meeting for 4D Molecular Therapeutics Inc. Our host for today's call is Dr. John Milligan, Director and Executive Chairman.

I will now turn the call over to your host. Dr. Milligan, you may begin.

John Milligan
4D Molecular Therapeutics Inc - Executive Chairman of the Board

Good morning, ladies and gentlemen. I am John F. Milligan, Director and Executive Chairman of the Board of Directors of 4D Molecular Therapeutics. I welcome you to the virtual 2026 Annual Meeting of Stockholders. As previously announced, we are holding our 2026 Annual Meeting virtually this year to allow greater participation and improve communication and provide savings for our stockholders and the company.

Upon joining the meeting electronically, an agenda for the meeting should have become available on your screen. At the bottom of the screen, a list of rules of conduct for the meeting should be available. In order to conduct an orderly meeting, we ask that participants abide by these rules. We appreciate your cooperation in this matter.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot